A second thought on second look laparotomy

References

• Schwarts PE, Smith JP. Second-look operation in ovarian cancer. Amer J Obstet & Gynecol 1980; 138: 1124–30
   Google Scholar
• Luesley DM, Chan KK, Fielding JW, Hurlow R, Blackledge GR, Jordon JA. Second-look laparotomy in the management of epithelial ovarian carcinoma: An evaluation of fifty cases. Obstet Gynecol 1984; 64: 421–6
   PubMed Web of Science ®Google Scholar
• Duplat J, Ferriere JP, Gorbinet M, Legros M, Chollet P, Giraud B, Plagne R. Second-look laparotomy in managing of epithelial ovarian carcinoma. Cancer 1986; 57: 1627–31
   Google Scholar
• Niloff JM, Bast RC, Jr, Schaetzl RN, Knapp RC. Predictive value of CA-125 antigen levels in second-look procedures for ovarian cancer. Amer J Obstet & Gynecol 1985; 151: 981–6
   PubMed Web of Science ®Google Scholar
• Young RC. A second-look at second-look laparotomy. J Clin Oncol 1987; 5: 1311–3
   Google Scholar
• Ho AG, Beller U, Speyer JL, Clombo N, Wernz J, Beckman EM. A reassessment of the role of second-look laparotomy in advanced ovarian cancer. J Clin Oncol 1987; 5: 1316–21
   Google Scholar
• Sonnendecker E WW. Is routine second-look laparotomy for ovarian carcinoma justified. Gynecol Oncol 1988; 31: 249–55
   Google Scholar
• McCusker MC, Hoffman JS, Curry SL, Koulos JP, Gondos B. The role of second-look laparotomy in the treatment of epithelial ovarian cancer. Gynecol Oncol 1987; 28: 83–8
   Google Scholar
• Pondczaski ES, Stevens CW, Jr, Manetta A, Whitney CW, Larson JE, Mortel R. Use of second-look laparotomy in management of patients with ovarian epithelial malignancies. Gynecol Oncol 1987; 28: 205–14
   Google Scholar
• Silverman PM, Osborne M, Dunnick NR, Bandy LC. CT prior to second-look operation in ovarian carcinoma. Amer J Radio 1988; 150: 829–32
   Google Scholar
• Calkins AR, Stehman FB, Wass JL, Smirz LR, Ellis JH. Pitfalls in interpretation of computed tomography prior to second-look laparotomy in patients with ovarian cancer. Brit J Radiol 1987; 60: 975–9
   Google Scholar
• Zanaboni F, Vergadro F, Peresti M, Gallotti P, Lombardi F, Bolis G. Tumor antigen CA-125 as a marker of ovarian epithelial carcinoma. Gynecol Oncol 1987; 28: 61–7
   PubMed Web of Science ®Google Scholar
• Mogensen O, Mogensen B, Jakobsen A, Sell A. Measurement of the ovarian cancer associated antigen CA-125 prior to second-look operation. Eur J Cancer Clin Oncol 1988; 24: 1835–7
   PubMedGoogle Scholar
• Schilthuis MS, Aalders JG, Bouma J, Kooi H, Fleuren GJ, Willemse P HB, De-Bruijn H WA. Serum CA-125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumor recurrence. Brit J Obstet & Gynecol. 1987; 94: 202–7
   PubMedGoogle Scholar
• Fiorettia P, Gadducci A, Ferdeghini M, Bartolini T, Bianchi R, Facchini V. Correlation of CA-125 and CA-19 serum levels with clinical course and second-look findings in patients with ovarian carcinoma. Gynecol Oncol 1987; 28: 278–83
   Google Scholar
• Chambers SK, Chambers JT, Kohorn EI, Lawrence R, Schwarts PE. Evaluation of the role of second-look surgery in ovarian cancer. Obstet Gynecol 1988; 72: 404–8
   Google Scholar
• Runowicz CD. A critical assessment of the role of second-look surgery in ovarian carcinoma. Cancer Invest. 1987; 5: 479–85
   PubMed Web of Science ®Google Scholar
• Rubin SC, Hoskins WJ, Hakes TB, Markman M, Cain JM, Lewis JL, Jr. Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors. Amer J Obstet & Gynecol 1988; 159: 1094–8
   PubMed Web of Science ®Google Scholar
• Podratz K.C, Malkasian GD, Jr, Wieand HS, Cha SS, Lee RA, Stanhope CR, Willams TJ. Recurrent disease after negative second-look laparotomy in stage III and IV ovarian carcinoma. Gynecol Oncol 1988; 29: 274–82
   Google Scholar
• Joyux H, Szawlowski AW, Saint-Aubert B, Elazhary MM, Solassol C, Pujol H. Aggressive regional surgery for advanced ovarian carcinoma. Cancer 1986; 57142–7
   Google Scholar
• Sonnendecker EW, Beale PG. Radical surgery in patients referred with a diagnosis of unresectable ovarian cancer. S Afr Med J 1987; 71: 621–5
   Google Scholar
• Barnhill DR, Nash JD, Park RC. Second-look assessment for epithelial ovarian carcinoma: an update. Contemp Ob/ Gyn 1984; 32: 19–29
   Google Scholar
• Kuten A, Stein M, Steiner M, Rubinov R, Epelbaum R, Choen Y. Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma. Int J Radiat Oncol Biol Phys 1988; 14: 273–9
   Google Scholar
• Shelley WE, Starreveld AA, Carmichael JA, O'Connell G, Roy M, Swenerton K. Toxicity of abdomenopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamid therapy and second-look laparotomy. Obstet Gynecol 1988; 71: 327–32
   Google Scholar
• Richman CM, Podczaski E, Weiser PA, Herbst AL. Hex-amethylmelamin, cytophosphamid, adriamycin, cisplatin-um chemotherapy as initial and second line treatment of advanced ovarian carcinoma. Oncology 1986; 43: 12–7
   Google Scholar
• Varia M, Rosenman J, Venkatraman S, Askin F, Fowler W, Wolton L, Halle J, Currie J. Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer. Cancer 1988; 61(5)919–27
   Google Scholar
• Lippman SM, Alberts DS, Slymen DJ, Weiner S, Aristizab-Al SA, Luditch A, Davis JR, Surwit E.A. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration. Cancer 1988; 61: 2571–7
   PubMedGoogle Scholar
• Carmichael JA, Shelley WE, Brown LB, Fraser RC, Kjirk ME, Krepart GV, Levitt M, Roy M, Willan AR, Wilson KS. A predictive index of cure versus no cure in advance ovarian carcinoma patients - replacement of second-look laparotomy as a diagnostic test. Gynecol Oncol 1987; 27: 269–78
   Google Scholar